Embodiments of the invention relate generally to measurement systems and examples include methods, systems and apparatus employing motors and locking mechanisms for conducting measurements, including the detection and/or quantification of components in a mixture. Examples of microfluidic disks including tooth elements are described. The tooth elements may in some examples aid in aligning an assay region with a detection unit.
Automated measurement of samples is important in a number of industries, such as the chemical and biotechnology industries, where the concentration of certain components of the sample is of interest. For example, quantification of biomolecules such as proteins and nucleic acids from patient samples is an important area of research and commercial development. Quantification of biomolecules and other types of samples is typically performed by optical measurements including fluorescence, luminescence, or relative light absorption. Portable solutions for these applications are a large and growing segment of the overall market.
Measurement systems typically shift a platform containing the sample to bring the sample in alignment with an optical detection unit, or vice versa. This may be achieved by either stopping the sample when in alignment with the optical detection unit and conducting the measurement, or synchronizing light detection with an actively moving sample. Synchronized detection may be cumbersome at high speeds, and typically requires positional sensors on the platform and a high quality motor with feedback mechanisms to maintain a constant shifting speed. Additionally, the time at which the optics are in alignment with the detection region is very brief, requiring a high intensity signal to achieve a favorable signal to noise ratio. Therefore, synchronized detection is typically reserved for high cost or low sensitivity systems.
Certain details are set forth below to provide a sufficient understanding of embodiments of the invention. However, it will be clear to one skilled in the art that embodiments of the invention may be practiced without various of these particular details. In some instances, well-known chemical structures, chemical components, molecules, materials, electronic components, circuits, control signals, timing protocols, and software operations have not been shown in detail in order to avoid unnecessarily obscuring the described embodiments of the invention.
Disclosed herein are example embodiments of systems, apparatuses and methods for detecting and/or quantifying one or more components of a sample. Examples are described that include tooth elements for alignment of an assay region with a detection unit. As mentioned above, existing systems and methods for performing an assay may be cumbersome or offer limited sensitivity. Therefore, there may be a need for systems and methods to perform an assay quickly, accurately, and at a relatively low cost.
For example, stopping a sample at increments during optical, or other detection, measurement may be advantageous because of longer integration time for light or other signal collection, which may increase the signal to noise ratio and hence sensitivity. Accordingly, rather than continuously presenting different detection regions of samples to a detection unit, it may be desirable to present one region to the detection unit, stop for a measurement time, then present a next region of sample to the detection unit. However, the measurement system may need to allow multiple stops with high precision to ensure proper alignment between the sample and the detection unit. Stepper motors have been used to achieve multiple stops with high precision, but may be prohibitively costly to implement in some examples because of the cost of the stepper motor along with feedback sensors and driver circuitry to ensure proper alignment. Alignment precision may be limited to the minimum step size of the stepper motor and driver circuitry. Additionally, there may be a tradeoff between maximum spin rate of the stepper motor and the minimum step size. Therefore, stepper motors may not be well suited to systems that require low cost components or high speed sample processing.
The assay platform 100 may be formed from a variety of materials, such as metals, glasses, polymers, and combinations thereof. The assay platform 100 may be formed by known manufacturing methods, including, but not limited to, microfluidic manufacturing techniques, semiconductor manufacturing techniques. Techniques such as injection molding, cutting, or both, may be used. The assay platform 100 may be disposable in some examples. The assay platform 100 may be portable in some examples.
The assay platform 100 may be fabricated with detection regions 102A-102N positioned on its surface. The detection regions 102A-102N may be areas, such as chambers, reservoirs, or other openings in the platform, configured to house samples. In some examples, the detection regions 102A-102N may be narrower on their peripheral end in order to concentrate a component of a sample, as will be described below. The detection regions 102A-102N may be positioned at a fixed distance from one another. A fixed distance may allow for proper alignment between the detection regions 102A-102N and the detection unit 112. The detection regions 102A-102N may move along a first path 114 when driven by the motor 108.
The assay platform 100 may generally include any microfluidic components desirable or useful for conducting an assay including, but not limited to, inlet port(s), outlet port(s), channels, chambers, reservoirs, pumps, valves, mixers, vents, and the like. Multiple assays may generally be performed on one assay platform 100, with a detection portion of the assay taking place at the detection regions 102A-102N. Examples of assay platforms and systems which may be usable with the tooth elements and alignment techniques described herein include systems and assay platforms described in U.S. patent application Ser. No. 12/891,977 and Ser. No. 13/423,008, which applications are incorporated herein by reference in their entirety for any purpose.
Tooth elements 106A-106N may be provided on the periphery of the assay platform 100, for example along the circumference of a circularly-shaped assay platform 100. In some examples, the tooth elements 106A-106N may be provided on a surface of the assay platform 100 such that the tooth elements 106A-106N protrude in a direction perpendicular to the plane of the assay platform 100. The tooth elements 106A-106N may be formed separately and coupled (e.g. adhered or bonded) to the assay platform 100, or may be formed along with the assay platform 100 in a unitary structure (e.g. through cutting or injection molding). The tooth elements 106A-106N may be formed by any known manufacturing method, for example molding, thermoforming, cutting, or combinations thereof. One tooth element 106A-106N may be provided for each of the detection regions 102A-102N in some examples. Generally, the tooth elements 106A-106N are provided such that once movement of the assay platform 100 is stopped by engaging a tooth element 106A-106N, a corresponding detection region 102A-102N is in alignment with a detection unit. In some examples, one tooth element 106A-106N may be associated with multiple detection regions and either bring the multiple detection regions into alignment with corresponding multiple detection units or may bring a single detection region into alignment with a detection unit and the detection unit may be moved to also access another detection region during the stopped time period. In some examples, tooth elements 106A-106N may be placed adjacent (e.g. peripheral to in the case of circular disk embodiments) to the detection regions 102A-102N. Adjacent placement may facilitate proper alignment of the detection regions 102A-102N with the detection unit 112 when the assay platform is stopped by engaging the tooth element. The tooth elements 102A-102N may move along a second path 116 when the motor 108 is moving the assay platform 100.
The tooth elements 106A-106N may be shaped to engage with the impinging element 104. In some examples, the assay platform 100 may stop moving when one or more of the tooth elements 106A-106N engages with the impinging element 104. For example, the assay platform 100 in some examples may be spun to rotate each detection region of the assay platform past a detection unit. In some examples, spinning the assay platform 100 may also be used to facilitate performance of the assay (e.g. by centrifugal force, examples of which are described in co-pending applications listed above, for example). The tooth elements 106A-106N may be positioned such that one side of each tooth element 106A-106N is aligned with one of the detection regions 102A-102N. Thus, when the impinging element 104 engages with each tooth element 106A-106N, the corresponding detection region 102A-102N may be in a desired alignment, such as within a measurement area of the detection unit 112. For example, the detection unit 112 may be aligned with the impinging element 104 so that a measurement area of the detection unit may be aligned with the detection region 102A-102N that corresponds to the tooth element 106A-106N that is engaged with the impinging element 104. In some examples, the detection unit 112 may be placed in another position so that its measurement area aligns with a different detection region 102A-102N than the detection region 102A-102N corresponding to the tooth element 106A-106N engaged with the impinging element 104.
The impinging element 104 may include a movable structure configured to allow for movement of the assay platform when placed in a first position 118 and engage at least one tooth element 106A-106N when placed in a second position 120. The impinging element 104 may be communicatively coupled (e.g. electrically) to the controller 110. The controller 110 may provide a control signal to the impinging element 104 to place the impinging element in the first or the second position 120. In this manner, the controller 110 may provide a control signal to move the impinging element 104 to sequentially engage with each tooth element of the multiple tooth elements 106A-106N. The impinging element 104 may be shaped to securely engage with the tooth elements 106A-106N. For example, the impinging element 104 may have a flat surface that engages with a flat surface of the tooth elements 106A-106N. The impinging element 104 may have a complimentary feature as that of the tooth elements 106A-106N in some examples.
The detection unit 112 may perform measurements to detect and/or quantify an analyte in any or all of the detection regions present on the assay platform. The detection unit 112 may, for example, include an optical light sensor for performing optical measurements, such as fluorescence, luminescence, and/or relative light absorption. In some examples, other sensors (e.g. electrical sensors) may be included additionally or instead in the detection unit 112 to support other detection methodologies. The detection unit 112 may be mounted in a system in proximity to a mount for holding the assay platform 100. Generally, the detection unit 112 is positioned in a system such that when the impinging element 104 is engaged with one or more of the tooth elements 106A-106N, a corresponding detection region is aligned with the detection unit 112 such that detection unit 112 is positioned to take a measurement from the detection region, or to move in a known manner to the detection region. A mount may be provided in a system for receiving the assay platform which may generally be inserted into and removed from the system. The detection unit 112 may accordingly be positioned in a known manner relative to the mount to facilitate alignment between detection regions on platforms that may be placed on the mount and the detection unit 112.
In some examples, the detection unit 112 may take a measurement when the impinging element 104 is engaged with one or more of the tooth elements 106A-106N, thereby preventing or restricting the assay platform 100 from moving. It may be advantageous to take a measurement while the assay platform 100 is not moving in order to increase the integration time for light (or other signal) collection, which may increase the signal to noise ratio and hence sensitivity. The detection unit 112 may be positioned such that when the impinging element 104 is in the second position 120, the detection unit 112 is aligned with at least one of the multiple detection regions 102A-102N. The optical sensor of the detection unit 112 may be oriented towards the detection regions 102A-102N. In some examples, as shown in
It may be advantageous to identify the detection region from which each measurement was taken. In some examples, identification may be performed by manually observing which assay region was measured during one or more time intervals. However, it may be desirable to have another mechanism to identify which assay region corresponds with a particular measurement made by the detection unit. In some examples, barcodes or other identifying structures may be placed on the assay platform and may be read or recognized to associate a measurement made by the detection unit with a particular assay region.
The impinging element 104 may be configured for placement in a third position 200, in which the impinging element 104 may engage with the extended tooth element 106X. It may be advantageous to place the impinging element 104 in the third position 200 for measurements of individual samples placed in a predefined order in the detection regions 102A-102N. For example, the extended tooth element 106X may define a start point for sequential measurement of the multiple detection regions 102A-102N. In this example, the impinging element 104 may be set to the third position 200, and the assay platform 100 may be moved by the motor 108 until the impinging element 104 engages with the extended tooth element 106X. In this manner, it may be known that a first measurement taken by the detection unit 112 corresponds with the detection region 102A-102N associated with the extended tooth element 106X. The impinging element 104 may shift back and forth from the first position 118 to the second position 120 to sequentially stop the assay platform 100 so that each detection region 102A-102N then aligns with the measurement area of the detection unit 112. In this manner, measurements of samples placed in a predefined order in the detection regions 102A-102N may be taken and subsequently identified. Using the extended tooth element 106X to define the start point of the assay may avoid the need for a barcode or other mechanism for defining the start point, thereby reducing costs in some examples.
In an alternate embodiment, two solenoid motors may be used to implement the impinging element 104. That is, instead of a physical impinging element protruding from the assay platform, multiple solenoids may be employed for positioning. It may be advantageous in some examples to use two solenoid motors instead of other types of motors to reduce costs. In this embodiment, each solenoid motor may be positioned proximate to the assay platform 100 and oriented such that a solenoid associated with the motor may extend towards the multiple tooth elements 106A-106N and/or the extended tooth element 106X. When a first solenoid extends out, it may engage with the extended tooth element 106X to prevent movement of the assay platform 100 and define a start point of the assay. When a second solenoid extends out, it may sequentially engage with the multiple tooth elements 106A-106N.
In some examples, the motor 108 may apply a centrifugal force to an assay platform mounted in the system. Centrifugal force may be used to separate one or more components of one or more samples positioned within one or more of the multiple detection regions 102A-102N of the assay platform 100. For example, components of biological and clinical samples may need to be separated to facilitate measurement (e.g. detection and/or quantification) of an analyte. Applying a centrifugal force may achieve a separation of one or more components of the biological or clinical samples placed within one or more of the multiple detection regions 102A-102N. In some examples, a fluid sample positioned within one or more of the multiple detection regions 102A-102N may include a plurality of beads 300 having complexes formed thereon, in which individual ones of the complexes include a target analyte and a labeling agent bound to the beads 300 in cooperation with the target analyte. The fluid sample may also include free labeling agent 304 that may be unbound. The motor 108 may apply a centrifugal force to the fluid sample, whereby the beads 300 in the fluid sample may be transported responsive to the centrifugal force through a density media 302 to pellet out at the detection region 102A-102N. Free labeling agent 304 may have insufficient density to be transported through the density media 302 and may not be present at the detection region 102A-102N. It should be understood that the motor 108 may be configured to move the assay platform 100 to effect a separation of a variety of different types of mixtures placed in the multiple detection regions 102A-102N responsive to a centrifugal force. Examples of assays usable with examples of the present invention are described in the applications incorporated by reference above.
In some examples, the controller 110 may be communicatively coupled (e.g. electrically) to the motor 108. The controller 110 may be an electronic device, for example a computing device, that may transmit control signals at predefined times and/or predefined intervals to recipient devices. Additionally, the controller 110 may store timing information using a timing device, for example a timer integrated circuit. The control signals may be transmitted using an implementation of a protocol recognizable by the recipient devices. The recipient device may include the detection unit 112, the impinging element 104, and/or the motor 108. The controller 110 may receive user input that defines parameters of the measurement system, such as distance between each of the detection regions 102A-102N, rotational speed, etc. The controller 110 may provide control signals to the impinging element 104 to place the impinging element 104 in the first position 118, second position 120, third position 200 (in some examples), fourth position (in some examples), or combinations thereof. By placing the impinging element 104 in the second position 120, a tooth element 106A-106N on the assay platform 100 may be engaged, and the assay platform 100 may be stopped. Accordingly, following placement of the impinging element 104 in the second position 120 after a predetermined period of time, the controller 110 may provide control signals to the detection unit 112 to make a measurement. Following a measurement time the controller 110 may provide control signals to the impinging element 104 to place the impinging element in the first position 118, allowing the motor to move the assay platform 100 again. After a predetermined time, the controller 110 may again provide control signals to place the impinging element 104 in the second position 120. The predetermined time may be set such that the impinging element 104 is moved into the second position 120 in time to stop the assay platform such that a next detection region 102A-102N is aligned with the detection unit 112. In this manner, the controller 110 may provide control signals such that the impinging element 104 engages with each tooth element 106A-106N. The controller 110 may send control signals to the motor 108 to start and stop the motor 108. In some examples, the controller 110 may stop the motor 108 for a predetermined interval after the impinging element 104 engages with each tooth element 106A-106N. In some examples, the assay platform 100 is stopped when the impinging element 104 engaged with any of the tooth elements 106A-106N, and a measurement may be performed by the detection unit 108. It may be advantageous to stop the motor 108 when the assay platform 100 is stopped in order to reduce electrical noise originating from the active motor during analysis by the detection unit 108.
The motor 108 may move the assay platform 100 such that the multiple detection regions 102A-102N move along a first path 114 and the multiple tooth elements 106A-106N move along a second path 116. In some examples, the first path 114 and the second path 116 may be circular (see, e.g.,
In some examples, the detection unit 112 may align with different portions of the detection regions 102A-102N. It may be advantageous to move the detection unit 112 such that the measurement area of the detection unit 112 is directed to a particular portion of the detection regions 102A-102N when components of interest in a sample are manipulated to be positioned in the particular portion. For example, when a centrifugal force is applied to detection regions 102A-102N in a circular assay platform 100, the denser components may be transported to the peripheral end of the assay platform 100 while the less dense components will be more towards the center of the assay platform 100. Thus, if a measurement of the denser components is desired, then the detection unit 112 may be aligned with the peripheral end of the detection regions 102A-102N. Alternatively, if a measurement of the less dense components is desired, then the detection unit 112 may be aligned with the end of the detection regions 102A-102N closest to the center of the assay platform 100.
In some examples, a first side of each of the tooth elements 106A-106N may include an angular portion 600 to partially frustrate the motor 108 in a first direction (see, e.g.,
Operation 704 involves performing a measurement on the detection region using the detection unit. The measurement may be performed during the predetermined interval where the impinging element is engaged with multiple ones of the tooth elements. For example, the measurement may detect fluorescence present in the detection region, which may allow identification of analyte including, but not limited to biomolecules such as proteins, nucleic acids, or combinations thereof. The method of
From the foregoing it will be appreciated that, although specific embodiments of the invention have been described herein for purposes of illustration, various modifications may be made without deviating from the spirit and scope of the invention.
This application claims benefit under 35 U.S.C. 119(e) to U.S. provisional patent application Ser. No. 61/818,360, entitled “SYSTEM AND METHOD FOR CONTROLLING DISK ROTATION FOR BIOASSAY” filed May 1, 2013, which provisional application is incorporated herein by reference in its entirety for any purpose.
This invention was developed under Contract DE-AC04-94AL85000 between Sandia Corporation and the U.S. Department of Energy. The U.S. Government has certain rights in the invention.
Number | Name | Date | Kind |
---|---|---|---|
3555284 | Anderson | Jan 1971 | A |
3744974 | Maddox et al. | Jul 1973 | A |
4125375 | Hunter | Nov 1978 | A |
4156570 | Wardlaw | May 1979 | A |
4656143 | Baker et al. | Apr 1987 | A |
4683579 | Wardlaw | Jul 1987 | A |
5279936 | Vorpahl | Jan 1994 | A |
5635362 | Levine et al. | Jun 1997 | A |
5882903 | Andrevski et al. | Mar 1999 | A |
6153148 | Thomas | Nov 2000 | A |
6319469 | Mian et al. | Nov 2001 | B1 |
6503722 | Valkirs | Jan 2003 | B1 |
6887384 | Frechet et al. | May 2005 | B1 |
7033747 | Gordon | Apr 2006 | B2 |
7157049 | Valencia et al. | Jan 2007 | B2 |
7332326 | Kellogg et al. | Feb 2008 | B1 |
7758810 | Lee et al. | Jul 2010 | B2 |
20010055812 | Mian et al. | Dec 2001 | A1 |
20020098535 | Wang et al. | Jul 2002 | A1 |
20020151043 | Gordon | Oct 2002 | A1 |
20020164659 | Rao et al. | Nov 2002 | A1 |
20030124719 | Woodside | Jul 2003 | A1 |
20040072278 | Chou et al. | Apr 2004 | A1 |
20050186685 | Kange et al. | Aug 2005 | A1 |
20050215410 | Merino et al. | Sep 2005 | A1 |
20050282220 | Prober et al. | Dec 2005 | A1 |
20090004059 | Pugia et al. | Jan 2009 | A1 |
20090325186 | Hinnah et al. | Dec 2009 | A1 |
20100068754 | Kirakossian | Mar 2010 | A1 |
20100120596 | Froman et al. | May 2010 | A1 |
20100151560 | Wo et al. | Jun 2010 | A1 |
20110045958 | Pedrazzini | Feb 2011 | A1 |
20140273241 | Ochranek et al. | Sep 2014 | A1 |
Number | Date | Country |
---|---|---|
WO-2008143578 | Nov 2008 | WO |
WO 2009098237 | Aug 2009 | WO |
Entry |
---|
Abi-Samra, Kameel et al., “Infrared controlled waxes for liquid handling and storage on a CD-microfluidic platform”, The Royal Society of Chemistry; Lab on a Chip, 2011, 723-726. |
Ahanotu, et al., “Staphylococcal enterotoxin B as a Biological Weapon: Recognition, Management, and Surveillance of Staphylococcal enterotoxin”, Applied Biosafety; vol. 11 (3), 2006, 120-126. |
Albrecht, J.W. et al., “Micro Free-Flow IEF Enhanced by Active Cooling and Functionalized Gels”, Electrophoresis, 2006, pp. 4960-4969, vol. 27. |
Amersham, “Percoll: Methodology and Applications”, 2001, 1-84. |
Amukele, et al., “Ricin A-chain activity on stem-loop and unstructured DNA substrates.”, Biochemistry; vol. 44(11), Mar. 25, 2005, 4416-4425. |
Andersson, et al., “Parallel nanoliter microfluidic analysis system”, Clinical Chemistry, 2007. |
Baldwin, Robert L. , “How Hofmeister Ion Interactions Affect Protein Stability”, Biophysical Journal; vol. 71, Oct. 1996, 2056-2063. |
Berry, Scott M., “One-step Purification of Nucleic Acid for Gene Expression Analysis via Immiscible Filtration Assisted by Surface Tension”, Lap Chip, May 21, 2011. |
Boyko, Matthew et al., “Cell-Free DNA—a Marker to Predict Ischemic Brain Damage in a Rat Stroke Experimental Model”, Journal of Neurosurg Anesthesiol, vol. 23, No. 3, Jul. 2011, 222-228. |
Brigotti, et al., “Shiga toxin 1 acting on DNA in vitro is a heat-stable enzyme not requiring proteolytic activation”, Biochimie Journal; 86(45), 2004, 305-309. |
Carney, J. , “Rapid Diagnostic Tests Employing Latex Particles”, Analytical Proceedings, Apr. 1990, 99-100. |
Curtis, R. A. et al., “A Molecular approach to bioseparations: Protein-protein and protein-salt interactions”, Chemical Engineering Science; vol. 61, 2006, 907-923. |
Czeiger, David et al., “Measurement of Circulating Cell-Free DNA Levels by a New Simple Fluorescent Test in Patients With Primary Colorectal Cancer”, Am J Clin Pathol, 2011, 264-270. |
Endo, et al., “RNA N-Glycosidase Activity of Ricin A-chain. Mechanism of Action of the Toxic Lectin Ricin on Eukaryotic Ribosomes”, The Journal of Biological Chemistry, vol. 262, No. 17, Jun. 15, 1987, 8128-8130. |
Glorikian, Harry et al., “Smart-consumables product development: Implications for molecular disgnostics”, DX Direction, 2010, 12-16. |
Goldshtein, Hagit et al., “A Rapid Direct Fluorescent Assay for Cell-Free DNA Quantification in Biological Fluids”, Annals of Clinical Biochemistry, 2009, 488-494. |
Gorkin, et al., “Centrifugal microfluidics for biomedical applications”, www.rsc.org/loc; Lab on a Chip, May 2010, 1758-1773. |
Holmberg, et al., “Depurination of A4256 in 28 S rRNA by the Ribosome-inactivating Proteins from Barley and Ricin Results in Different Ribosome Conformations”, Journal of Molecular Biology; vol. 259(1), May 31, 1996, 81-94. |
Holmes, David et al., “Leukocyte analysis and differentiation using high speed microfluidic single cell impedance cytometry”, Lab on a Chip 9, Aug. 7, 2009, 2881-2889. |
Huang, et al., “The Primary Structure of Staphylococcal enterotoxin B. III. The Cyanogen Bromide Peptides of Reduced and Aminoethylated Enterotoxin B, and the Complete Amino Acid Sequence.”, The Journal of Biological Chemistry vol. 245 No. 14, Jul. 25, 1970, 3518-3525. |
Lee, et al., “Fully integrated lab-on-a-disc for simultaneous analysis of biochemistry and immunoassay from whole blood”, Lab Chip, 2011. |
Lee, B. S. et al., “A fully automated immunoassay from whole blood on a disc”, Lab on a Chip 9, Mar. 5, 2009, 1548-1555. |
Lim, C. T. et al., “Bead-based microfluidic immunoassays: The next generation”, Biosensors Bioelectronics 22, Jul. 20, 2006, 1197-1204. |
Lo, C.T. et al., “Photopolyermerized Diffusion-Defined Polyacrylamide Gradient Gels for On-Chip Protein Sizing”, The royal Society of Chemistry, Lab on a Chip, vol. 8, No. 8, 2008, pp. 1273-1279. |
Lo, Y. M. D. et al., “Plasma DNA as a Prognostic Marker in Trauma Patients”, Clinical Chemistry 46:3, 2000, 319-323. |
Madou, Marc et al., “LAB on a CD”, Annual Rev. Biomed Eng 8, May 2006, 601-628. |
Maes, Melissa L. et al., “Comparison of Sample Fixation and the use of LDS-751 or anti-CD45 or Leukocyte Identification in Mouse Whole Blood for Flow Cytometry”, Journal of Immunological Methods, 319(1-2) Jan. 30, 2007, 79-86. |
Min, Junhong et al., “Functional Integration of DNA Purification and Concentration Into a Real Time Micro-PCR Chip”, The Royal Society of Chemistry; Lab on a Chip, 2011, 259-265. |
Price, Christopher P. et al., “Light-Scattering Immunoassay”, Principles and Practice of Immunoassay (Second Edition); Chapter 18, 1997, 445-480. |
Rhodes, Andrew et al., “Plasma DNA concentration as a predictor of mortality and sepsis in critically ill patients”, Critical Care, 2006, 1-7. |
Rider, Todd H. et al., “A B Cell-Based Sensor for Rapid Identification of Pathogens”, www.sciencemag.org; Science Volume. 301, Jul. 11, 2003, 213-215. |
Riegger, L. et al., “Read-out concepts for multiplexed bead-based fluorescence immunoassays on centrifugal microfluidic platforms”, Sensors and Actuators A-Physical, 2006, 455-462. |
Saukkonen, et al., “Cell-Free Plasma DNA as a Predictor of Outcome in Severe Sepsis and Septic Shock”, Clinical Chemistry; vol. 54:6, 2008, 1000-1007. |
Schaff, et al., “Whole Blood Immunoassay Based on Centrifugal Bead Sedimentation”, Clinical Chemistry Automation and Analytical Techniques 57:5, 2011, 753-761. |
Schembri, et al., “Portable Simultaneous Multiple Analyte Whole-Blood Analyzer for Point-of-Care Testing”, Clinical Chemistry 38/9, 1992, 1665-1670. |
Schneider, et al., “Characterization of EBV-Genome Negative “Null” and “T” Cell Lines Derived From Children With Acute Lymphoblastic Leukemia and Leukemic Transformed Non-Hodgkin Lymphoma”, International Journal of Cancer; 19(5), May 15, 1977, 621-626. |
Yu, et al., “Bioinformatic processing to identify single nucleotide polymorphism that potentially affect Ape1 function.”, Mutation Research/Genetic Toxicology and Environmental Mutagenesis; vol. 722(2), Jun. 17, 2011, 140-146. |
Zhang, L. et al., “A New Biodosimetric Method: Branched Dna-Based Quantitative Detection of B1 Dna in Mouse Plasma”, The British Journal of Radiology, vol. 83, Aug. 2010, 694-701. |
Ziegler, Annemarie et al., “Circulating DNA: a new diagnostic gold mine?”, Cancer Treatment Reviews, vol. 28, 2002, 255-271. |
Churchill et al., “Detection of Listeria monocytogenes and the toxin listeriolysin O in food”, Journal of Microbiological Methods, 2006; 64:141-170. |
McBain et al., Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection, Journal of Materials Chemistry, 17, pp. 2561-2565, available online Apr. 13, 2007. |
Riahi et al. Analytical Chemistry. 2011. 83(16): 6349-6354 and Supporting Information. |
Melting Temperature Calculation. Retrieved on asf from the internet: http://www.biophp.org/minitools/melting—temperature/demo.php?primer=CGT+TAC+CCG+CAG&basic-1&NearestNeighbor=1&cp=200&cs=50&cmg=0, Jul. 2015. |
Berlier et al. The Journal of Histochemistry and Cytochemistry. 2003. 51(12): 1699-1712. |
PubChem Search results for “2,3-dihydroxypropyl octanoate”. Retrieved on Oct. 5, 2016 from the internet: https://www.hcbi.nim.nih.gov/pccompound/?term=2%2C3-dihydroxypropyl+octanoate. (4 pp.). |
PubChem entry for TWEEN 20. Retrieved on Oct. 4, 2016 from the internet: https://pubchem.ncbi.nlm.nih.gov/compound/Tween—20#section=Names-and-identifiers. (2 pp.). |
Sigma-Aldrich product page for TWEEN 20 archived from Jun. 28, 2012. Retrieved on Oct. 5, 2016 from the internet: https://web.archive.org/web/20120628080753/http://www.sigmaaldrich.com/catalog.product/sial/p1379?ang=en®ion=. (43 pp.). |
Number | Date | Country | |
---|---|---|---|
61818360 | May 2013 | US |